Aarti Patel

ORCID: 0000-0001-6192-474X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cardiovascular Function and Risk Factors
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Cardiac Valve Diseases and Treatments
  • Cancer Treatment and Pharmacology
  • Cardiac Imaging and Diagnostics
  • Infective Endocarditis Diagnosis and Management
  • Viral Infections and Immunology Research
  • Cardiac Structural Anomalies and Repair
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac tumors and thrombi
  • Pericarditis and Cardiac Tamponade
  • Aortic Disease and Treatment Approaches
  • Vascular Procedures and Complications
  • Acute Myocardial Infarction Research
  • Cardiac electrophysiology and arrhythmias
  • Coronary Artery Anomalies
  • Genetic Neurodegenerative Diseases
  • Vascular anomalies and interventions
  • Radiation Dose and Imaging
  • Cardiac Arrhythmias and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Lipoproteins and Cardiovascular Health
  • Cardiomyopathy and Myosin Studies

University of South Florida
2013-2022

University of Alberta Hospital
2021

Janssen (United States)
2011-2019

Janssen Scientific Affairs (United States)
2011-2019

Moffitt Cancer Center
2017

Tampa General Hospital
2016-2017

AdventHealth Tampa
2016

Memorial Hospital
2016

Memorial Hospital
2014

Patel Hospital
2012

Objectives There is little information about arrhythmia burden in cancer survivors with chemotherapy-induced cardiomyopathy (CIC). We hypothesise that the rates and risk of arrhythmias will be similar CIC when compared other non-ischaemic (NICMO) aetiologies. Methods retrospectively identified nine patients an implantable defibrillator 18 age sex-matched control (nine NICMO ischaemic (ICMO)). Rates odds were calculated by type cardiomyopathy, adjusting for days since cardioverter...

10.1136/openhrt-2017-000701 article EN cc-by-nc Open Heart 2017-12-01

Bortezomib is a proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma. Traditionally, bortezomib was thought have little cardiovascular toxicity; however, there increasing evidence that can lead cardiac complications including left ventricular dysfunction atrioventricular block. We present the case of 66-year-old man with persistent asymptomatic elevations biomarkers who developed complete heart block myocardial scar after his eighth cycle bortezomib, requiring...

10.1155/2016/3456287 article EN cc-by Case Reports in Cardiology 2016-01-01

Background Left ventricular noncompaction ( LVNC ) is a rare disorder characterized by increased left trabeculation, deep intertrabecular recesses, and thin compacted myocardial layer with associated clinical sequelae. Cardiac imaging echocardiogram cardiac magnetic resonance CMRI can detect variable morphology including excessive trabeculations. Multiple echocardiographic criteria have been offered that attempt to identify morphology. The aim of this study was assess the utility in...

10.1002/clc.22669 article EN Clinical Cardiology 2017-03-07

Friedreich's ataxia (FRDA) is an autosomal recessive disease, whereby homozygous inheritance of expanded GAA trinucleotide repeat expansion in the first intron FXN gene leads to transcriptional repression encoded protein frataxin. FRDA a progressive neurodegenerative disorder, but primary cause death heart disease which occurs 60% patients. Several functions frataxin have been proposed, none them fully explain why its deficiency causes phenotypes nor most affected cell types are neurons and...

10.1002/mgg3.2093 article EN cc-by-nc-nd Molecular Genetics & Genomic Medicine 2022-11-11

Ventricular pseudoaneurysm is an uncommon, potentially fatal complication that has been associated with myocardial infarction, cardiac surgery, chest trauma, and infectious processes. Diagnosis can be challenging, as cases are rare slowly progressing typically lack identifiable features on clinical presentation. As a result, advanced imaging techniques have become the hallmark of identification. Ahead, we describe patient who presents acute decompensated heart failure was incidentally...

10.1155/2017/4352474 article EN cc-by Case Reports in Cardiology 2017-01-01

Background: Optimal timing to initiate anticoagulation after Acute Ischemic Stroke (AIS) from Atrial Fibrillation (AF) is currently unknown. Compared other stroke etiologies, AF typically provokes larger infarct volumes and greater concern of hemorrhagic transformation, so seminal randomized trials waited weeks-to-months begin initial stroke. Subsequent data limited nonrandomized. Guidelines suggest initiation windows between 3 14 days post-stroke, with Class IIa recommendations, level...

10.3389/fneur.2019.00975 article EN cc-by Frontiers in Neurology 2019-09-20

10.1007/s11936-016-0450-1 article EN Current Treatment Options in Cardiovascular Medicine 2016-02-27

Central MessagePatients who undergo tricuspid valvectomy may develop symptoms of right-sided heart failure and require operative reintervention with valve replacement.See Commentary on page 68. Patients replacement. See The incidence infective endocarditis secondary to intravenous (IV) drug abuse has risen sharply during the opioid epidemic in United States.1Slaughter M.S. Badhwar V. Ising M. Ganzel B.L. Sell-Dottin K. Jawitz O.K. et al.Optimum surgical treatment for endocarditis: an...

10.1016/j.xjtc.2022.01.017 article EN JTCVS Techniques 2022-01-20

The effects of Echinacea purpurea on electrocardiographic and blood pressure measurements in healthy volunteers were evaluated.Healthy randomized to receive a single 350-mg dose E. or placebo crossover fashion with seven-day washout period between treatment phases. Twelve-lead electrocardiograms acquired, systolic diastolic taken immediately before (baseline) at one, three, five, eight hours after ingestion the study drug. Electrocardiographic variables (P wave QRS complex duration PR, Q-T,...

10.2146/ajhp070056 article EN American Journal of Health-System Pharmacy 2007-07-23

Abstract Based upon its interactions with amyloid β peptide (Aβ), the amylin receptor, a Class B G protein-coupled receptor (GPCR), is potential modulator of Alzheimer’s disease (AD) pathogenesis. However, past pharmacological approaches have failed to resolve whether activation or blockade this would greater therapeutic benefit. To address issue, we generated compound mice expressing human precursor protein gene familial AD mutations in combination deficiency receptors produced by...

10.21203/rs.3.rs-515476/v1 preprint EN cc-by Research Square (Research Square) 2021-05-19

Peripartum cardiomyopathy is an uncommon, pregnancy-related form of dilated that associated with development new-onset left ventricular dysfunction. Its etiology presently unknown, but current standard care involves the use typical drug therapy for treatment heart failure. Pregnancy-associated (PACM) a similar condition refers to patients who develop such symptoms prior last month pregnancy. We report case nulliparous Caucasian female develops early, severe PACM during her first pregnancy...

10.1155/2017/9561405 article EN cc-by Case Reports in Cardiology 2017-01-01
Coming Soon ...